Protocol Ledger

NCT04102371 · Phase III · COMPLETED

Pragmatic Pediatric Trial of Balanced Versus Normal Saline Fluid in Sepsis

Interventional Phase III clinical trial protocol NCT04102371 sponsored by Children's Hospital of Philadelphia in Infectious Disease and Vaccines, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2020-08-25 Enrollment: 9,041 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT04102371
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)9,041 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT04102371
Protocol FieldVerified Registry Value
NCT IdentifierNCT04102371
Consolidated Lead SponsorChildren's Hospital of Philadelphia
Therapeutic Condition CohortInfectious Disease and Vaccines
Clinical Trial PhasePhase III
Overall Recruitment StatusCOMPLETED
Registered Enrollment9,041 participants (ACTUAL)
Registered Start Date2020-08-25
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for Children's Hospital of Philadelphia across sibling Meru public-data platforms.

Search related sites and sponsors in the Interactive Directory, explore Infectious Disease and Vaccines Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI